Chapter/Section Purchase

1 Study Coverage
1.1 Human Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Human Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-Exposure Vaccine
1.3.3 Post-Exposure Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Rabies Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Human Rabies Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Rabies Vaccine Sales by Region
2.4.1 Global Human Rabies Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Human Rabies Vaccine by Region (2023-2028)
2.5 Global Human Rabies Vaccine Revenue by Region
2.5.1 Global Human Rabies Vaccine Revenue by Region (2017-2022)
2.5.2 Global Human Rabies Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Rabies Vaccine Sales by Manufacturers
3.1.1 Global Top Human Rabies Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Human Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Vaccine in 2021
3.2 Global Human Rabies Vaccine Revenue by Manufacturers
3.2.1 Global Human Rabies Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccine Revenue in 2021
3.3 Global Human Rabies Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Rabies Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Rabies Vaccine Sales by Type
4.1.1 Global Human Rabies Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Human Rabies Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Rabies Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Human Rabies Vaccine Revenue by Type
4.2.1 Global Human Rabies Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Human Rabies Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Rabies Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Human Rabies Vaccine Price by Type
4.3.1 Global Human Rabies Vaccine Price by Type (2017-2022)
4.3.2 Global Human Rabies Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Rabies Vaccine Sales by Application
5.1.1 Global Human Rabies Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Human Rabies Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Rabies Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Human Rabies Vaccine Revenue by Application
5.2.1 Global Human Rabies Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Human Rabies Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Rabies Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Human Rabies Vaccine Price by Application
5.3.1 Global Human Rabies Vaccine Price by Application (2017-2022)
5.3.2 Global Human Rabies Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Rabies Vaccine Market Size by Type
6.1.1 North America Human Rabies Vaccine Sales by Type (2017-2028)
6.1.2 North America Human Rabies Vaccine Revenue by Type (2017-2028)
6.2 North America Human Rabies Vaccine Market Size by Application
6.2.1 North America Human Rabies Vaccine Sales by Application (2017-2028)
6.2.2 North America Human Rabies Vaccine Revenue by Application (2017-2028)
6.3 North America Human Rabies Vaccine Market Size by Country
6.3.1 North America Human Rabies Vaccine Sales by Country (2017-2028)
6.3.2 North America Human Rabies Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Human Rabies Vaccine Market Size by Type
7.1.1 Europe Human Rabies Vaccine Sales by Type (2017-2028)
7.1.2 Europe Human Rabies Vaccine Revenue by Type (2017-2028)
7.2 Europe Human Rabies Vaccine Market Size by Application
7.2.1 Europe Human Rabies Vaccine Sales by Application (2017-2028)
7.2.2 Europe Human Rabies Vaccine Revenue by Application (2017-2028)
7.3 Europe Human Rabies Vaccine Market Size by Country
7.3.1 Europe Human Rabies Vaccine Sales by Country (2017-2028)
7.3.2 Europe Human Rabies Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Rabies Vaccine Market Size by Type
8.1.1 Asia Pacific Human Rabies Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Rabies Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Human Rabies Vaccine Market Size by Application
8.2.1 Asia Pacific Human Rabies Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Rabies Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Human Rabies Vaccine Market Size by Region
8.3.1 Asia Pacific Human Rabies Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Rabies Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Human Rabies Vaccine Market Size by Type
9.1.1 Latin America Human Rabies Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Human Rabies Vaccine Revenue by Type (2017-2028)
9.2 Latin America Human Rabies Vaccine Market Size by Application
9.2.1 Latin America Human Rabies Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Human Rabies Vaccine Revenue by Application (2017-2028)
9.3 Latin America Human Rabies Vaccine Market Size by Country
9.3.1 Latin America Human Rabies Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Human Rabies Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Rabies Vaccine Market Size by Type
10.1.1 Middle East and Africa Human Rabies Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Rabies Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Rabies Vaccine Market Size by Application
10.2.1 Middle East and Africa Human Rabies Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Rabies Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Rabies Vaccine Market Size by Country
10.3.1 Middle East and Africa Human Rabies Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Rabies Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Corporation Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bharat Biotech Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Bavarian Nordic
11.2.1 Bavarian Nordic Corporation Information
11.2.2 Bavarian Nordic Overview
11.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bavarian Nordic Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic Recent Developments
11.3 Sanofi-Pasteur
11.3.1 Sanofi-Pasteur Corporation Information
11.3.2 Sanofi-Pasteur Overview
11.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Pasteur Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Pasteur Recent Developments
11.4 Chengda Bio
11.4.1 Chengda Bio Corporation Information
11.4.2 Chengda Bio Overview
11.4.3 Chengda Bio Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chengda Bio Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chengda Bio Recent Developments
11.5 KANGH
11.5.1 KANGH Corporation Information
11.5.2 KANGH Overview
11.5.3 KANGH Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 KANGH Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 KANGH Recent Developments
11.6 Prcmise
11.6.1 Prcmise Corporation Information
11.6.2 Prcmise Overview
11.6.3 Prcmise Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Prcmise Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prcmise Recent Developments
11.7 Henan Grand Biopharma
11.7.1 Henan Grand Biopharma Corporation Information
11.7.2 Henan Grand Biopharma Overview
11.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Henan Grand Biopharma Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Henan Grand Biopharma Recent Developments
11.8 Zhuoyi Biological
11.8.1 Zhuoyi Biological Corporation Information
11.8.2 Zhuoyi Biological Overview
11.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhuoyi Biological Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhuoyi Biological Recent Developments
11.9 ZhongKe Biopharm
11.9.1 ZhongKe Biopharm Corporation Information
11.9.2 ZhongKe Biopharm Overview
11.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ZhongKe Biopharm Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ZhongKe Biopharm Recent Developments
11.10 Ningbo Rongan Biological
11.10.1 Ningbo Rongan Biological Corporation Information
11.10.2 Ningbo Rongan Biological Overview
11.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ningbo Rongan Biological Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ningbo Rongan Biological Recent Developments
11.11 Indian Immunologicals
11.11.1 Indian Immunologicals Corporation Information
11.11.2 Indian Immunologicals Overview
11.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Indian Immunologicals Human Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Rabies Vaccine Industry Chain Analysis
12.2 Human Rabies Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Rabies Vaccine Production Mode & Process
12.4 Human Rabies Vaccine Sales and Marketing
12.4.1 Human Rabies Vaccine Sales Channels
12.4.2 Human Rabies Vaccine Distributors
12.5 Human Rabies Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Rabies Vaccine Industry Trends
13.2 Human Rabies Vaccine Market Drivers
13.3 Human Rabies Vaccine Market Challenges
13.4 Human Rabies Vaccine Market Restraints
14 Key Findings in The Global Human Rabies Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer